HIV infection
448 results
1 - 100
Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection- Micronutrient supplementation for children with HIV infection
- Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection: Cochrane systematic review
- Treatment of latent tuberculosis infection in HIV infected persons
- Yellow fever vaccine for patients with HIV infection
- Telephone delivered interventions for preventing HIV infection in HIV‐negative persons
- Herbal medicines for treating HIV infection and AIDS
- Treatment for leiomyosarcoma and leiomyoma in children with HIV infection
- Micronutrient supplementation in pregnant women with HIV infection
- Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV
- Treatment of Kaposi sarcoma in children with HIV‐1 infection
- Isoniazid for preventing tuberculosis in HIV‐infected children
- Micronutrient supplementation in adults with HIV infection
- Vaginal disinfection for preventing mother‐to‐child transmission of HIV infection
- Antiretrovirals for reducing the risk of mother‐to‐child transmission of HIV infection
- Antidepressants for depression in adults with HIV infection
- Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection
- Population‐based biomedical sexually transmitted infection control interventions for reducing HIV infection
- Sperm washing to prevent HIV transmission from HIV‐infected men but allowing conception in sero‐discordant couples
- Hormonal contraception for women at risk of HIV infection
- Interventions for squamous cell carcinoma of the conjunctiva in HIV‐infected individuals
- Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection
- Point‐of‐care tests detecting HIV nucleic acids for diagnosis of HIV‐1 or HIV‐2 infection in infants and children aged 18 months or less
- Anabolic steroids for the treatment of weight loss in HIV‐infected individuals
- Isoniazid for preventing tuberculosis in non‐HIV infected persons
- Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults
- Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection
- Treatment of severe or progressive Kaposi's sarcoma in HIV‐infected adults
- Oral substitution treatment of injecting opioid users for prevention of HIV infection
- Nonoxynol‐9 for preventing vaginal acquisition of HIV infection by women from men
- Telephone delivered interventions for reducing morbidity and mortality in people with HIV infection
- Abstinence‐plus programs for HIV infection prevention in high‐income countries
- Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection
- Interventions for the treatment of decreased bone mineral density associated with HIV infection
- Antiretroviral therapy (ART) for treating HIV infection in ART‐eligible pregnant women
- Integrating prevention of mother‐to‐child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries
- Three‐ or four‐ versus two‐drug antiretroviral maintenance regimens for HIV infection
- Telephone communication of HIV testing results for improving knowledge of HIV infection status: Cochrane systematic review
- Abstinence‐only programs for HIV infection prevention in high‐income countries
- Management of toxoplasmic encephalitis in HIV‐infected adults (with an emphasis on resource‐poor settings)
- Strategies for partner notification for sexually transmitted infections, including HIV
- Hormonal contraception for women exposed to HIV infection: Cochrane systematic review
- Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS
- Interventions for reducing the risk of mother-to-child transmission of HIV infection: Cochrane systematic review
- Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children
- Home‐based care for reducing morbidity and mortality in people infected with HIV/AIDS
- Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.
- Interventions to improve adherence to antiretroviral therapy in children with HIV infection
- School‐based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents
- Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole
- Optimisation of antiretroviral therapy in HIV‐infected children under 3 years of age
- Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in high‐income countries
- Stavudine or zidovudine in three‐drug combination therapy for initial treatment of HIV infection in antiretroviral‐naïve individuals
- Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV‐infected, treatment‐naive adults
- Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection
- Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults
- Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group B Streptococcal and HIV)
- Low dose versus high dose stavudine for treating people with HIV infection
- Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in low‐ and middle‐income countries
- Structural and community‐level interventions for increasing condom use to prevent the transmission of HIV and other sexually transmitted infections
- Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults: Cochrane systematic review
- Optimal time for initiating antiretroviral therapy (ART) in HIV‐infected, treatment‐naive children aged 2 to 5 years old
- Interventions to reduce risky sexual behaviour for preventing HIV infection in workers in occupational settings: Cochrane systematic review
- Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
- Tenofovir or zidovudine in three‐drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non‐nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral‐naïve individuals
- Efavirenz or nevirapine in three‐drug combination therapy with two nucleoside or nucleotide‐reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral‐naïve individuals
- Interventions for the prevention of mycobacterium avium complex in adults and children with HIV: Cochrane systematic review